'Universal' influenza vaccine development underway in Europe

December 4, 2013
Development of a 'universal' influenza vaccine underway in Europe
Credit: Shutterstock

A newly launched European project is set to take a major step toward the development of a universal flu vaccine. It aims to counter the emergence of new strains and seasonal epidemics.

The viral infection usually strikes in colder months with being responsible for around 3 - 5 million cases of severe illness and 250,000 to 500,000 deaths worldwide.

Due to its rapid spread particularly among high risk population groups, remains a serious public health problem. To date, the most effective way to prevent the disease or severe symptoms is annual vaccination but current vaccines only offer limited protection against evolving strains of the infection.

To overcome these weaknesses, a public-private partnership comprising seven renowned organisations from Europe joined forces under the EDUFLUVAC project to develop a broad-spectrum, long-lasting against influenza.

EDUFLUVAC launched into action only a month ago and aims to take a novel approach by 'educating' the immune system to cross-recognise common regions within multiple strains.

'Developing a universal has become a global health priority for preventing the spread of the virus and the emergence of new strains, and we are convinced that EDUFLUVAC will be a major step forward towards achieving this goal', says Othmar Engelhardt, principal investigator at the National Institute for Biological Standards and Control, United Kingdom.'

The research team expects to achieve better protection against epidemic influenza through the development of a vaccine that would not only offer the tremendous advantage of eliminating the need for a seasonal vaccine every year but could also reduce the need for costly annual vaccination campaigns.

Odile Leroy, Executive Director of the European Vaccine Initiative and coordinator of EDUFLUVAC, says: 'Low and middle-income countries currently have minimal programmes. Thus, the development of a vaccine that elicits broad long-lasting defence would facilitate vaccination campaigns and confer protection against influenza in hitherto untargeted groups with limited health care'.

The four-year project is coordinated by the European Vaccine Initiative headquartered in Germany and was awarded a grant of EUR 4.6 million in EU funding.

Explore further: FDA approves first 4-in-1 flu vaccine

More information: Project factsheet: cordis.europa.eu/projects/rcn/110279_en.html

Related Stories

FDA approves first 4-in-1 flu vaccine

February 29, 2012

Federal health officials have approved the first vaccine that protects against four strains of the common flu, offering one additional layer of protection against the influenza virus that affects millions each year.

FDA approves H5N1 avian influenza vaccine

November 26, 2013

(HealthDay)—The U.S. Food and Drug Administration has approved the first adjuvanted vaccine for the prevention of H5N1 influenza in adults at greater-than-average risk of exposure.

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...

Computer model reveals deadly route of Ebola outbreak

November 10, 2015

Using a novel statistical model, a research team led by Columbia University's Mailman School of Public Health mapped the spread of the 2014-2015 Ebola outbreak in Sierra Leone, providing the most detailed picture to date ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.